Tumor necrosis factor-alpha and mortality in heart failure: a community study. - Wikidata - wikimedia - TriplyDB

Tumor necrosis factor-alpha and mortality in heart failure: a community study.

Tumor necrosis factor-alpha and mortality in heart failure: a community study.

http://www.wikidata.org/entity/Q37192858

about

Impact of anti-inflammatory agents on the gene expression profile of stimulated human neutrophils: unraveling endogenous resolution pathways Type D personality is a predictor of poor emotional quality of life in primary care heart failure patients independent of depressive symptoms and New York Heart Association functional class.Circulating levels of tumor necrosis factor-alpha receptor 2 are increased in heart failure with preserved ejection fraction relative to heart failure with reduced ejection fraction: evidence for a divergence in pathophysiology Targeted gene-silencing reveals the functional significance of myocardin signaling in the failing heart Clinical and serum-based markers are associated with death within 1 year of de novo implant in primary prevention ICD recipients.Cellular proliferative response to cardiac troponin-I in patients with idiopathic dilated cardiomyopathy.High fat diet enhances cardiac abnormalities in SHR rats: Protective role of heme oxygenase-adiponectin axis.Lifetime exposure to traumatic psychological stress is associated with elevated inflammation in the Heart and Soul Study.Toxicological effect of TiO2 nanoparticle-induced myocarditis in mice.Inflammatory Biomarkers in Refractory Congestive Heart Failure Patients Treated with Peritoneal Dialysis Ambient temperature and biomarkers of heart failure: a repeated measures analysis.Changes in the monocytic subsets CD14(dim)CD16(+) and CD14(++)CD16(-) in chronic systolic heart failure patients.Evaluation and comparison of biomarkers in heart failure Post-infarct remodelling: contribution of wound healing and inflammation.Prevalence of anemia in heart failure and its effects on prognosis.The role of exercise on L-arginine nitric oxide pathway in chronic heart failure.Cardio-Ankle Vascular Index and C-Reactive Protein Are Useful Parameters for Identification of Ischemic Heart Disease in Acute Heart Failure Patients.Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome.Positioning of inflammatory biomarkers in the heart failure landscape.Biomarkers of heart failure with normal ejection fraction: a systematic review.Targeting macrophage subsets for infarct repair.Role of tumor necrosis factor alpha in the pathogenesis of atrial fibrillation: A novel potential therapeutic target?Low Plasma Testosterone Is Associated With Elevated Cardiovascular Disease Biomarkers.Cytokines and matrix metalloproteinases as potential biomarkers in chronic heart failure.The protective effect of thalidomide on left ventricular function in a rat model of diabetic cardiomyopathy.Role of cardiac inflammation in right ventricular failure.Inflammatory cytokines in chronic heart failure: interleukin-8 is associated with adverse outcome. Results from CORONA.The role of serum VCAM-1 and TNF-α as predictors of mortality and morbidity in patients with chronic heart failure.Plasma concentrations of tumour necrosis factor-alpha, tumour necrosis factor-related apoptosis-inducing ligand, and FasLigand/CD95L in patients with Chagas cardiomyopathy correlate with left ventricular dysfunction.Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction.Resident and Monocyte-Derived Macrophages in Cardiovascular Disease.Myocardial (123)I-mIBG scintigraphy in relation to markers of inflammation and long-term clinical outcome in patients with stable chronic heart failure.Activation of Class I histone deacetylases contributes to mitochondrial dysfunction in cardiomyocytes with altered complex activities.Receptor activator of nuclear factor-κB ligand is a novel inducer of myocardial inflammation.Tumor necrosis factor-α and its role as a mediator in myocardial infarction: A brief review.Pro-Inflammatory Biomarkers in Stable Versus Acutely Decompensated Heart Failure With Preserved Ejection Fraction.Cystatin C, NT-proBNP, and inflammatory markers in acute heart failure: insights into the cardiorenal syndrome

P2860

Q33419375-91BAFE91-AF50-4D5E-B49B-884134BF8474 Q33619172-7B206D05-77E3-4C87-9273-E3DC9B740C27 Q33748856-38440BB8-10AC-4F2C-BCDF-4F93EA30F2FA Q34058563-8AFEA2B8-17DB-4C4B-BB58-50812E2E7A00 Q35001908-7A3CAB13-E7E3-4605-95A2-C379C415E773 Q35492692-AC8681B4-3738-4A07-B108-FB27C9231935 Q35680257-3A00367C-A197-467D-A457-736AAB3D88DA Q35878093-8EF61A1F-05CC-4EF8-A707-ECE447CFB1C9 Q35946850-3811A6BE-5E17-4EAA-A66E-159F49C11AF1 Q36204135-CDA25B66-8DE0-46A5-ABCB-5E94065890AB Q36229049-FF26585F-4A32-4528-88A4-8CDBEB3D2063 Q36446773-AC5D5265-4D1D-4332-8296-E9EDA661451E Q36776556-85E28D90-1605-4810-AA3C-2AD6BFF600EE Q37314909-162F8598-1141-4221-90C9-D80A900FAD25 Q37390743-197FB16F-FAAC-45BE-B592-A7830E5EA871 Q37416187-4A505630-F851-4061-B3C9-5C2786C74831 Q37737195-DDF14F5F-7B2E-4EBA-A849-FFDE752E85D7 Q37891878-651378CC-668F-4C7B-AD77-C9A1C78BA6A8 Q38105986-6D35E030-A39A-4064-8202-2CF6A03865D7 Q38120919-CFD8B97B-BCF1-4960-84E8-F2617AD54740 Q38221014-CD4A9DC4-CF09-4ECF-80A1-C17A99B0ADD5 Q38486305-7B88F075-C57E-4D13-B8D9-B62E6072BB5F Q38652939-67DA5BBD-C438-49EE-8A57-36C66E91AEC1 Q39900053-BC783BAC-4AD5-4D9A-94C2-6AD73376E036 Q42986845-56960B06-1248-47E5-BECF-1FF0AE688885 Q45068688-DF5F3701-0047-433B-A1B8-E4EAC0D5F430 Q46927699-7B263F00-1F61-407A-A177-B5A6C0E9E0A9 Q48194839-0DE6A1D5-7F21-4808-BB77-0E0365616880 Q48494535-E757E122-47F1-4BA7-9AD3-2D44826ACAC7 Q48725493-6A5ADB38-ADC7-4820-9D61-664788A5ECAE Q50187351-39F4EE44-80E0-4658-8FC4-8865B150B9C2 Q51321052-59B8A11C-16F3-4961-84A1-5BFF16758D20 Q52333566-26A0F58B-660F-4474-98BB-4E296B42555B Q53188305-887EB5F3-4903-4BF8-BCDF-97E802576FAB Q54953158-19E72FE6-CC4F-4F73-9A6D-4ED6EA8A47E1 Q55499529-03A1C759-A9AD-4861-BE5E-E3E4F32D3FD0 Q57543438-FFE7FB41-3AD9-47D3-A40F-52B88F57C8B0

P2860

Tumor necrosis factor-alpha and mortality in heart failure: a community study.

http://www.wikidata.org/entity/Q37192858

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 July 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Tumor necrosis factor-alpha and mortality in heart failure: a community study.

@en

Tumor necrosis factor-alpha and mortality in heart failure: a community study.

@nl

type

label

Tumor necrosis factor-alpha and mortality in heart failure: a community study.

@en

Tumor necrosis factor-alpha and mortality in heart failure: a community study.

@nl

prefLabel

Tumor necrosis factor-alpha and mortality in heart failure: a community study.

@en

Tumor necrosis factor-alpha and mortality in heart failure: a community study.

@nl

P1433

Q37192858-ACD1E61A-9DA0-4F6B-BD3D-C872C66D4B48

P1476

Q37192858-752CBF4B-F013-4003-9EA4-621D7F0F60C0

P2093

Q37192858-247B70B5-DB2A-42DD-BC4F-9C388074C8A5

Q37192858-4F675625-B855-4413-96E6-1516226C94F6

Q37192858-70CE20F5-4857-4706-A54E-71B8D27F5808

Q37192858-A25F3824-476D-46A2-A504-9EB8FBDA525A

Q37192858-B403298F-57A5-49E8-B265-7871995B63E8

P2860

Q37192858-0775B853-734F-40D2-BE80-C0E01CC19464

Q37192858-106FE465-9581-482B-B012-0FCE454371C9

Q37192858-11319D6C-CBE4-4481-AFE1-79928EDE9511

Q37192858-1B6D85CC-450D-455D-8EF8-EAB8FFD47778

Q37192858-2DB4A692-3E44-4722-B1D7-57F60F4FDD4D

Q37192858-371E87FB-8876-4BDC-A66D-442FF745DE02

Q37192858-3CEF360F-AD43-490A-847A-BDC56E90F904

Q37192858-42604B28-1C06-409B-ABA4-5944A00E070F

Q37192858-42B328A5-BD01-406D-A54D-6AB68F0B0D68

Q37192858-4816799B-5AE8-427B-9C48-C96263246BBB

P304

Q37192858-33A631C6-4A6C-4313-BCBB-7A2BA0EBAFD1

P31

Q37192858-345F79F0-66AC-4878-9388-8DF307A9F36B

P356

Q37192858-00426CB0-90A6-4FE6-A8E4-2EADE204F328

P407

Q37192858-8D3F215D-9014-42C5-82D8-FB00AF6E3769

P433

Q37192858-8ACE7902-02CD-4B76-9455-57C6E0898216

P478

Q37192858-46952B33-B2D2-48E1-8F29-793B6F1923E9

P577

Q37192858-024F926C-FB55-4293-92C7-6DACF116B67B

P5875

Q37192858-E7684807-5699-4979-A71F-1C6FEFF76E9B

P698

Q37192858-749FDFC3-71FA-4812-A2A6-755A4E5AE94D

P921

Q37192858-00BEE9AD-6E09-48E5-B4D0-E795BEFAB3F8

P932

Q37192858-52C3A979-CAC0-45C4-8444-5F174830452A

P356

CIRCULATIONAHA.107.759191

P1433

P1476

Tumor necrosis factor-alpha and mortality in heart failure: a community study.

@en

P2093

Jill M Killian

http://www.w3.org/2001/XMLSchema#string

Margaret M Redfield

http://www.w3.org/2001/XMLSchema#string

Shannon M Dunlay

http://www.w3.org/2001/XMLSchema#string

Susan A Weston

http://www.w3.org/2001/XMLSchema#string

Véronique L Roger

http://www.w3.org/2001/XMLSchema#string

P2860

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Prediction of creatinine clearance from serum creatinine

Increased circulating cytokines in patients with myocarditis and cardiomyopathy.

Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration.

Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study.

A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

History of the Rochester Epidemiology Project.

Coronary disease surveillance in Olmsted County objectives and methodology.

P304

625-631

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.107.759191

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P577

2008-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51418985

http://www.w3.org/2001/XMLSchema#string

P698

18645056

http://www.w3.org/2001/XMLSchema#string

P921

P932

2682349

http://www.w3.org/2001/XMLSchema#string